Page last updated: 2024-08-25
7-hydroxystaurosporine and African Lymphoma
7-hydroxystaurosporine has been researched along with African Lymphoma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Eastman, A; Fan, S; O'Connor, PM; Sausville, EA; Wang, Q; Worland, PJ | 1 |
Other Studies
1 other study(ies) available for 7-hydroxystaurosporine and African Lymphoma
| Article | Year |
|---|---|
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Topics: Alkaloids; Antineoplastic Agents; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Division; Cell Survival; Cisplatin; Colonic Neoplasms; Cyclin B; Cyclin B1; Cyclins; Drug Synergism; Flow Cytometry; G2 Phase; Gamma Rays; Genes, p53; Humans; Immunoblotting; Mitotic Index; Mutation; Precipitin Tests; Radiation Dosage; Staurosporine; Tumor Cells, Cultured | 1996 |